IDT Australia Limited (ASX: IDT) - Share Price

- Current share price for IDT : $0.038

IDT Australia Limited (IDT) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a pharmaceutical manufacturer with five decades of experience in the production of pharmaceuticals from the laboratory bench to the patient.

IDT General Information ⁺

ASX Code	IDT
Website	http://www.idtaus.com.au
Industry/Sector	Pharmaceuticals
Market Cap ($M)	16
IDT Share Price	$0.038
Day High	$0.038
Day Low	$0.038
Last Close	$0.038
IDT Share Price Movement	- ( No change )

Prices as at 16:40, 23 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

IDT Australia Limited (IDT) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
Interim	1¢	100%	12 Apr 2010	30 Apr 2010	-	-	-
Final	5¢	100%	2 Oct 2009	23 Oct 2009	-	-	-
Interim	5.5¢	100%	6 Apr 2009	28 Apr 2009	-	-	-

See all dividends from IDT Australia Limited (IDT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

IDT Australia Limited (IDT) price-sensitive announcements

IDT - FY26 Appendix 4E and Annual Report

The FY26 Appendix 4E and Annual Report for IDT Australia Limited details the financial per

IDT Australia Limited (IDT)
20 Aug 2026 | 10:35 AM

IDT - Upgrade to FY26 Guidance

IDT Australia Limited has announced an upgrade to its financial guidance for the fiscal ye

IDT Australia Limited (IDT)
21 Jul 2026 | 2:18 PM

IDT - March Quarter Update & Positive FY26 Guidance

IDT Australia Limited has provided an update for the March quarter of FY26, highlighting a

IDT Australia Limited (IDT)
28 Apr 2026 | 10:03 AM

IDT - 1HFY26 Results Presentation

The 1HFY26 results for IDT Australia Limited highlight the company's strategic realignment

IDT Australia Limited (IDT)
18 Feb 2026 | 10:14 AM

IDT Australia Limited (IDT) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
IDT Australia Limited (IDT) ORDINARY FULLY PAID	Health Care	$16	Proposed issue of securities - IDT	23 Oct 2026 4:59PM	$0.038	$0.038	fallen by 0%
IDT Australia Limited (IDT) ORDINARY FULLY PAID	Health Care	$16	Notification regarding unquoted securities - IDT	23 Oct 2026 4:55PM	$0.038	$0.038	fallen by 0%
IDT Australia Limited (IDT) ORDINARY FULLY PAID	Health Care	$16	Notice of Annual General Meeting and Proxy Form	16 Oct 2026 1:40PM	$0.038	$0.038	fallen by 0%
IDT Australia Limited (IDT) ORDINARY FULLY PAID	Health Care	$16	Change in substantial holding	6 Oct 2026 5:23PM	$0.040	$0.038	fallen by 5%
IDT Australia Limited (IDT) ORDINARY FULLY PAID	Health Care	$16	Cleansing Notice	5 Oct 2026 2:51PM	$0.041	$0.038	fallen by 7.32%
IDT Australia Limited (IDT) ORDINARY FULLY PAID	Health Care	$16	Application for quotation of securities - IDT	5 Oct 2026 2:39PM	$0.041	$0.038	fallen by 7.32%

IDT Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2026A	-$2.72	-$0.70	-64.60%	0.00%	0.0%
2025A	-$8.06	-$1.90	21.90%	0.00%	0.0%
2024A	-$5.41	-$1.60	-54.30%	0.00%	0.0%

IDT Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Clarity Pharmaceuticals Ltd (CU6)	$625M	0.4454	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
IDT Australia Limited (IDT)	$16M	-0.6455	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Neuren Pharmaceuticals Limited (NEU)	$2,511M	-0.7857	0.2462	0.9655	85.1311	68.3103	34.7544	0.00%	1.67%	1.97%

IDT Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	0.85	0.00
Market	0.30	13.30	1.03	0.72
Sector	0.78	41.90	2.29	2.12

IDT Directors

Name	Position	Start Date
Mr Geoffrey Joseph Sam	Non-Executive Director	10 Oct 2022
Dr Jane Ryan	Non-Executive Director	28 Jan 2022
Mr Mark Anthony Simari	Non-Executive Director, Non-Executive Chairman	10 Oct 2022

IDT Australia Limited (IDT) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
12 May 2026	SAM, Geoffrey	Buy	Indirect Shares	125,000	$0.039	$4,875.000
30 Apr 2026	SAM, Geoffrey	Buy	Indirect Shares	489,695	$0.041	$19,904.800
24 Mar 2026	SIMARI, Mark	Buy	Indirect Shares	325,000	$0.045	$14,557.190

See all changes in directors' interest & trades for IDT Australia Limited (IDT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IDT Management

Name	Position
J Sosic	Chief Operating Officer
N R M Perera	Head of Finance
Paul Joseph Mcdonald	Chief Executive Officer
Mr Vasanthakumar	Chief Financial Officer
Mark Andrew Licciardo	Company Secretary

IDT Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in IDT Australia Limited (IDT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
82,904,358 (19.40%)	Palm Beach Nominees Pty Limited
30,753,053 (7.19%)	HSBC Custody Nominees (Australia) Limited
26,890,150 (6.29%)	Citicorp Nominees Pty Limited
23,926,666 (5.60%)	Ubs Nominees Pty Ltd
12,828,815 (4.40%)	Anthony Huntley

IDT Calendar of Events

Date	Event
19 August 2027	Report (Annual)
19 August 2027	Report (Prelim)
17 February 2027	Report (Interim)
18 November 2026	AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us